ProAssurance (PRA) President Merrick Sells $1.3M of Stock

A subsidiary president's million-dollar sale joins a wave of insider transactions at the Birmingham-based insurance provider.

Reviewed by automated data checks against the source filing. How we make and check alerts

Shook Kevin Merrick, President of a Subsidiary at ProAssurance Corporation ($PRA), sold 53,237 shares at an average price of $25, worth about $1.33 million, on June 26, 2026. The trade was reported to the SEC in a Form 4 filing.

Find the original: PRA Form 4 filings on SEC EDGAR

PRA ProAssurance Corporation
$25 +4.08% year to date
Daily close · Jun 25, 2026

Key Points

  • Kevin Merrick Shook, President of a ProAssurance subsidiary, sold 53,237 shares on June 26, 2026, for a total transaction value of $1,330,925.
  • The sale coincided with six other insider disposals on the same day, all executed at $25.00 per share as the stock traded near its 52-week high.
  • ProAssurance reported annual revenue of $1.10 billion and maintains a price-to-earnings ratio of 19.8, with its next earnings report expected on August 4, 2026.

Get $PRA trade alerts by text

We text you when insiders, Congress or big funds trade $PRA. Free.

Not investment advice. EarningsIQ is not a registered investment adviser, and this automated ProAssurance Corporation alert may contain errors. Disclosures

Kevin Merrick Shook, who serves as the President of a subsidiary for ProAssurance Corporation (NYSE: PRA), sold 53,237 shares of the company on June 26, 2026. This transaction was valued at approximately $1.33 million and was disclosed in a regulatory filing with the SEC. The sale was executed at a price of $25.00 per share.

Wave of Insider Selling at ProAssurance

This transaction was not an isolated event. On the same day, a broad group of insiders at the company also sold their holdings. Director Di Piazza Samuel JR. sold 44,952 shares for about $1.12 million, while Robert David Francis, who leads the Healthcare Professional Liability division, sold 31,196 shares worth $779,900. Other participants in this selling activity included Frei Maye Head, who disposed of 31,298 shares, and Fabiloa Cobarrubias, who sold 25,184 shares. Additionally, Staci Pierce and Richard Bielen each sold 10,621 shares. All of these transactions occurred on June 26, 2026, at the $25.00 price point, and none were reported as being part of a Rule 10b5-1 trading plan.

ProAssurance Stock Performance

On Saturday, the stock was positioned at $25.00, which sits at the very top of its one-year trading range of $22.80 to $25.02. The company currently has a market value of roughly $1.29 billion. Investors may note that the stock is trading just above its 50-day moving average of $24.61 and its 200-day moving average of $24.31. This price stability comes even as the company faces a modest 4.9% decline in revenue growth.

Financial Health and Earnings

In its most recent financial reporting, ProAssurance generated $1.10 billion in revenue and reported earnings per share of $1.26. The company is currently profitable, showing a net margin of 5.95% and a return on equity of 5.07%. With a price-to-earnings ratio of 19.8, the stock's valuation is closely aligned with its forward P/E of 20.0. The company’s balance sheet shows a current ratio of 2.06, suggesting it has enough short-term assets to cover its immediate liabilities.

Professional Liability and Specialty Insurance

ProAssurance is a niche insurance provider based in Birmingham, Alabama. It focuses on property and casualty insurance, specifically for the healthcare and legal industries. The company provides liability coverage for doctors, hospitals, and lawyers, as well as workers' compensation and medical technology insurance. This specialized focus means its performance is often tied to the legal and regulatory environment surrounding professional liability in the United States.

What's Ahead for ProAssurance Corporation

Investors typically watch insider sales to see how executives view their own company's valuation, though selling can happen for many personal financial reasons. The next major catalyst for the stock will likely be the second-quarter earnings release, which is scheduled for August 4, 2026. These insider filings are backward-looking and show what happened on the transaction date, so they don't necessarily reflect the current sentiment of the executives today.

Source: Shook Kevin Merrick's Form 4 filing on $PRA (Jun 26, 2026). Find the original filing: PRA Form 4 filings on SEC EDGAR. Written by software, not financial advice. How we make alerts

Get $PRA trade alerts by text